Cano Health (CANO) Scheduled to Post Quarterly Earnings on Monday

Cano Health (NYSE:CANO – Get Rating) will post its quarterly earnings results before the market opens on Monday, May 9th. Analysts expect Cano Health to post earnings of ($0.02) per share for the quarter. Cano Health has set its FY 2022 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.

Cano Health (NYSE:CANO – Get Rating) last posted its quarterly earnings results on Monday, March 14th. The company reported ($0.12) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.11). The firm had revenue of $492.26 million for the quarter, compared to analysts’ expectations of $524.88 million. On average, analysts expect Cano Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

NYSE:CANO opened at $5.30 on Monday. The company’s 50 day moving average price is $5.74 and its 200-day moving average price is $7.71. Cano Health has a 52 week low of $4.17 and a 52 week high of $16.17. The company has a current ratio of 1.97, a quick ratio of 1.96 and a debt-to-equity ratio of 1.15.

CANO has been the topic of a number of recent analyst reports. Piper Sandler cut shares of Cano Health from a “neutral” rating to an “underweight” rating and cut their price target for the company from $8.50 to $5.00 in a report on Wednesday, April 6th. Zacks Investment Research upgraded shares of Cano Health from a “sell” rating to a “hold” rating in a report on Tuesday, March 15th. Credit Suisse Group cut their price target on shares of Cano Health from $15.00 to $13.00 and set an “outperform” rating on the stock in a report on Wednesday, March 16th. UBS Group initiated coverage on shares of Cano Health in a research report on Wednesday, April 20th. They set a “buy” rating and a $15.00 price objective on the stock. Finally, Citigroup lowered their price objective on shares of Cano Health from $12.00 to $10.00 in a research report on Wednesday, March 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $13.00.

In other Cano Health news, Director Lewis Gold purchased 300,000 shares of the firm’s stock in a transaction on Thursday, March 17th. The shares were acquired at an average cost of $6.81 per share, for a total transaction of $2,043,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 54.40% of the stock is currently owned by company insiders.

Several hedge funds have recently made changes to their positions in the company. Bank of America Corp DE bought a new stake in shares of Cano Health during the 2nd quarter valued at $139,000. Invesco Ltd. bought a new stake in shares of Cano Health during the 4th quarter valued at $133,000. Squarepoint Ops LLC bought a new stake in shares of Cano Health during the 4th quarter valued at $375,000. Royal Bank of Canada raised its position in shares of Cano Health by 3,807.8% during the 3rd quarter. Royal Bank of Canada now owns 54,709 shares of the company’s stock valued at $694,000 after purchasing an additional 53,309 shares during the period. Finally, Legal & General Group Plc purchased a new position in Cano Health during the fourth quarter valued at $545,000. Hedge funds and other institutional investors own 37.64% of the company’s stock.

About Cano Health (Get Rating)

Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.

Further Reading